This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of ...

Known in past decade as a horse tranquilizer and surgical anesthetic, ketamine is now gaining popularity as a party drug and even a life-coping aid. But while it shows promise in treating depression, ...

Esketamine, a form of ketamine taken as a nasal spray, has been approved for the treatment for moderate to severe treatment-resistant depression in Scotland but intravenous ketamine has not, though it ...

RISE Integrated Mental Health in York, Maine, offers ketamine therapy for trauma and depression, attracting patients ...

Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...

Offering proven success and lasting results, ketamine represents hope and healing in the treatment of depression, anxiety, ...

Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.

Ketamine is an anesthetic that has been growing in use as an off-label prescription to treat depression. Individuals can access the drug through telehealth appointments and clinics in person.

Ketamine has been used for decades as an anaesthetic drug, but in the past few years, more and more psychiatrists have been using it for hard-to-treat depression ...